Latest Tag: Biosafety Resources

– By ACB Research and Advocacy Officer Sabrina Masinjila & Executive Director Mariam Mayet For several years, the ACB has engaged at multiple levels with the development of the Post-2020 Global Biodiversity Framework (GBF). In the lead up to the Convention on Biological Diversity (CBD) Conservation’s fifteenth Conference of Parties (COP 15), held in Montreal, Canada in […]

– A blog by ACB Director Mariam Mayet Snapshot In October 2021, the South African (SA) government determined that the regulatory and risk assessment framework that exists for genetically modified organisms (GMOs) will also apply to new breeding techniques (NBTs), which make up a host of new genetic engineering technologies. This decision appears to follow […]

A coalition of non-governmental organisations, farmer groups and research experts from various African countries call on the Nigerian government to revoke the permits granted by Nigeria’s National Biosafety Management Agency (NBMA) to the Institute for Agricultural Research (IAR), Zaria, for the commercial release of genetically modified (Bt) Cowpea (PBR-Cowpea). This call was made yesterday in […]

ACB brings you a new discussion paper Passer à la version française Clique aqui para a versão portuguesa Dear Friends and Colleagues, Expeditious and affordable access to medicines and other healthcare items will be critical to reducing the toll of COVID-19 in Africa. But if nothing is done to compel corporations to make their patents […]

The news that the Swaziland Environmental Authority (SEA) had authorised the importation and commercial release of Bt cotton seeds came as a huge shock to the African Centre for Biodiversity (ACB). It meant that ACB had to reconsider its earlier acceptance of an invitation by SEA to attend a National Biosafety Indaba on 22 May […]

In this objection, ACB raises numerous concerns with the application by Monsanto for the commercial release of the triple stacked event. Drought tolerance is a highly complex genetic trait that cannot be addressed by single gene insertions, as shown by the lack of data backing up the applicant’s claim that this GM variety shows “improvements […]

Biosafety TWN Briefing – Biosafety aspects of genome-editing techniques. You can download the paper here.

The African Centre for Biosafety (ACB) was very recently handed a copy of the Common Market for Eastern and Southern Africa’s (COMESA) ‘Draft policy statements and guidelines for commercial planting of GMOs, Trade in GMOs and Emergency Food aid with GMO content’. Having perused the policy we are alarmed and outraged that COMESA appears to […]

Across the world, the use of bilateral trade instruments to prise open markets for genetically modified (GM) crops is escalating. To expand business overseas, the biotech industry needs stronger intellectual property rules and weaker biosafety standards. Bilateral trade deals are an effective way to do this. This report looks specifically at how the world’s grain […]

The genetic engineering (GE) industry is facing a shrinking global market as more and more countries adopt biosafety laws and GE labelling regulations. Africa and Asia are the new frontiers for exploitation by the agro-chemical, seed and GE corporations. The United States Agency for International Development (USAID) appears to be at the forefront of a […]

The paper is a response to concerns raised by the African Union’s Biosafety Unit about assertions made in an earlier briefing in June 2009 regarding the African Union’s biosafety harmonisation processes. In this briefing the Ms Swanby on behalf of the ACB salutes the initiatives taken by the AU in the biosafety discourse on the […]

In July 2009 The African Union Biosafety Unit communicated their concerns about the ACB’s briefing no.9, their letter can be viewed here. The original briefing can be viewed at here, The ACB’s response is titled On-going concerns about harmonisation of biosafety regulations in Africa, November 2009.